FETO-MATERNAL RISK FACTOR ASSOCIATED TO THE MODERATELY AND EXTREMELY OBESE PREGNANT WOMAN IN COMPARISON TO THE NORMAL WEIGHTED PREGNANT CASES (PRIMIGRAVIDA AND MULTIGRAVIDA CASES): A COMPARATIVE COHORT RESEARCH

Journal Title: Indo American Journal of Pharmaceutical Sciences - Year 2018, Vol 5, Issue 5

Abstract

Objective: The comparison of the adverse Feto-maternal outcomes in both the groups of Normal and overweight pregnant woman was the objective of this particular research. Methods: Design of the research was comparative cohort, which was completed in the time span of November, 2016 to October, 2018 (Mayo Hospital, Lahore) on a sample of 200 gravid ladies. Sample was divided into two main groups named as overweight and normal pregnant women of hundred cases each. Sample was comprised of pregnant women having gestational age in the range of 08 weeks – 40 weeks. Overweight and normal cases were categorized respectively as (BMI 25 – 29.9 Kg/m2) and (BMI of 18.5 – 24.9), normal cases were taken as controls. Feto-maternal outcomes were compared through Chi-square test and the pvalue was taken as (< 0.05). Results: Women selected for the research were in the age bracket of 30 – 45 years with a mean age of (30 ± 4.1 years). High frequency of pre-eclampsia was observed in overweight women in comparison to the normal group (27% vs 9%), gestational diabetes mellitus (DM) (22% vs 5%), PIH (24% vs 8%), Caesarean section (44% vs 16%), prolonged labor (4% vs 6%), Postpartum Hemorrhage (5% vs 2%) and Wound infection (3% vs 2%). The significant P-value was taken as (< 0.001). In terms of fetal complications in both the groups when compared were as Early neonatal death (11% vs 1%), Still birth (13% vs 2%), NICU admission (47% vs 10%) and shoulder dystocia (5% vs 1%). Except the incidence of shoulder dystocia outcomes were statistically significant. Conclusion: It is concluded that deleterious effects are related to the incidence of obesity on the Feto-maternal outcomes. Key Words: Outcomes, Controls, Pregnant Overweight Women and Adverse Feto-maternal.

Authors and Affiliations

Keywords

Related Articles

DETERMINATION OF BIOACTIVE COMPOUNDS FROM PIPER BETLE L. BY USING HP-LC ANALYSIS

Medicinal plants are being used since ancient time without knowing about its active ingredients. The healing power of certain plant was understood and accepted before mankind discovered the existence of microorganisms. H...

ESTIMATION OF DIFFERENT EXTRACTS OF AMARANTHUS VIRIDIS L FOR INVITRO ANTIOXIDANT ACTIVITY

Back ground: The plant Amaranthus viridis L (Amaranthaceous) is commonly known as “Never-fading flower” and “Slender amaranth” in Greek and English respectively. These plants have been traditionally used as antiulcer, an...

AN EXPLORATORY REVIEW OF THE MYTHS AND COMMON BELIEFS ABOUT ACNE AND ITS TREATMENT

Objective: To assess considerations of patients about various dietary and preventive factors of acne regarding their disease and treatment Methods and Results:100 patients presenting with Acne Vulgaris to Out Patient Dep...

INVITRO ANTIOXIDANT ACTIVITIES OF CHLOROFORM EXTRACT OF ANISOMELES MALABARICA.

Herbal medicines and Phytochemicals can be potent agents for lung cancer chemoprevention and treatment by regulating multi-molecular targets involved in angiogenesis, metastasis, and severe side effects; only provided qu...

STUDIES ON THE DESIGN, SYNTHESIS AND ANTITUBERCULAR ACTIVITY OF SOME NEW QUINAZOLINONE DERIVATIVES

Quinazolinone derivatives are the versatile nitrogen containing heterocyclic compounds displaying a wide variety of biological and pharmacological activities like antibacterial, anthelmintic,neuroleptic,antitubercular,pl...

Download PDF file
  • EP ID EP292403
  • DOI -
  • Views 282
  • Downloads 0

How To Cite

(2018). FETO-MATERNAL RISK FACTOR ASSOCIATED TO THE MODERATELY AND EXTREMELY OBESE PREGNANT WOMAN IN COMPARISON TO THE NORMAL WEIGHTED PREGNANT CASES (PRIMIGRAVIDA AND MULTIGRAVIDA CASES): A COMPARATIVE COHORT RESEARCH. Indo American Journal of Pharmaceutical Sciences, 5(5), 4317-4323. https://europub.co.uk/articles/-A-292403